Literature DB >> 33836616

Loss of expression of both miR-15/16 loci in CML transition to blast crisis.

Francesca Lovat1,2, Pierluigi Gasparini1,2,3, Giovanni Nigita1,2, Karilyn Larkin2,4, John C Byrd2,4, Mark D Minden5, Michael Andreeff6, Bing Z Carter6, Carlo M Croce7,2.   

Abstract

Despite advances that have improved the treatment of chronic myeloid leukemia (CML) patients in chronic phase, the mechanisms of the transition from chronic phase CML to blast crisis (BC) are not fully understood. Considering the key role of miR-15/16 loci in the pathogenesis of myeloid and lymphocytic leukemia, here we aimed to correlate the expression of miR-15a/16 and miR-15b/16 to progression of CML from chronic phase to BC. We analyzed the expression of the two miR-15/16 clusters in 17 CML patients in chronic phase and 22 patients in BC and in 11 paired chronic phase and BC CML patients. BC CMLs show a significant reduction of the expression of miR-15a/-15b/16 compared to CMLs in chronic phase. Moreover, BC CMLs showed an overexpression of miR-15/16 direct targets such as Bmi-1, ROR1, and Bcl-2 compared to CMLs in chronic phase. This study highlights the loss of both miR-15/16 clusters as a potential oncogenic driver in the transition from chronic phase to BC in CML patients.

Entities:  

Keywords:  blast crisis; chronic myeloid leukemia; miR-15/16 cluster

Year:  2021        PMID: 33836616      PMCID: PMC7980455          DOI: 10.1073/pnas.2101566118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  The biology of chronic myeloid leukemia.

Authors:  S Faderl; M Talpaz; Z Estrov; S O'Brien; R Kurzrock; H M Kantarjian
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

2.  Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia.

Authors:  M Chowdhury; K Mihara; S Yasunaga; M Ohtaki; Y Takihara; A Kimura
Journal:  Leukemia       Date:  2007-03-22       Impact factor: 11.528

3.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Manuela Ferracin; Amelia Cimmino; Gianpiero Di Leva; Masayoshi Shimizu; Sylwia E Wojcik; Marilena V Iorio; Rosa Visone; Nurettin Ilfer Sever; Muller Fabbri; Rodolfo Iuliano; Tiziana Palumbo; Flavia Pichiorri; Claudia Roldo; Ramiro Garzon; Cinzia Sevignani; Laura Rassenti; Hansjuerg Alder; Stefano Volinia; Chang-gong Liu; Thomas J Kipps; Massimo Negrini; Carlo M Croce
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

4.  Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants.

Authors:  Francesca Corradini; Vincenzo Cesi; Viviana Bartella; Elisabetta Pani; Rita Bussolari; Olivia Candini; Bruno Calabretta
Journal:  J Biol Chem       Date:  2005-05-31       Impact factor: 5.157

5.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

6.  Knockout of both miR-15/16 loci induces acute myeloid leukemia.

Authors:  Francesca Lovat; Matteo Fassan; Diana Sacchi; Parvathi Ranganathan; Alexey Palamarchuk; Marius Bill; Malith Karunasiri; Pierluigi Gasparini; Giovanni Nigita; Rosario Distefano; Dario Veneziano; Adrienne M Dorrance; Ramiro Garzon; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-26       Impact factor: 11.205

Review 7.  Causes and consequences of microRNA dysregulation in cancer.

Authors:  Carlo M Croce
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

8.  BMI1 gene expression in myeloid leukemias and its impact on prognosis.

Authors:  Niveen S Saudy; Iman M Fawzy; Emad Azmy; Enas F Goda; Asmaa Eneen; Eman M Abdul Salam
Journal:  Blood Cells Mol Dis       Date:  2014-07-30       Impact factor: 3.039

9.  Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia.

Authors:  P G Pelicci; L Lanfrancone; M D Brathwaite; S R Wolman; R Dalla-Favera
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

10.  Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Authors:  Wei Wang; Jorge E Cortes; Guilin Tang; Joseph D Khoury; Sa Wang; Carlos E Bueso-Ramos; Joseph A DiGiuseppe; Zi Chen; Hagop M Kantarjian; L Jeffrey Medeiros; Shimin Hu
Journal:  Blood       Date:  2016-03-22       Impact factor: 22.113

View more
  3 in total

Review 1.  Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?

Authors:  Bilal Abdulmawjood; Beatriz Costa; Catarina Roma-Rodrigues; Pedro V Baptista; Alexandra R Fernandes
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

Review 2.  Small Non-Coding RNAs in Leukemia.

Authors:  Veronica Balatti; Carlo M Croce
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

Review 3.  Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia.

Authors:  Christian Boni; Claudio Sorio
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.